Serac Healthcare

Develops molecular imaging agents for clinicians treating endometriosis, interstitial lung disease and inflammatory arthritis

London, United KingdomFounded 2017serachealthcare.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-15

About Serac Healthcare

Serac Healthcare is developing 99mTc-maraciclatide, a molecular imaging agent for endometriosis, interstitial lung disease and inflammatory arthritis. The imaging approach is being investigated to help clinicians assess disease activity and distinguish inflammation from fibrosis.

The company works with academic partners at King’s College London, the University of Leeds and the University of Oxford. Serac Healthcare Ltd was founded in 2017 and is registered in London, United Kingdom.

Product: Develops 99mTc-maraciclatide, a molecular imaging agent being investigated for several inflammatory conditions.

Jobs at Serac Healthcare

No open positions listed right now.

More biotech & pharma companies

  • Seren Plus

    Wholesale supplier of prescription medicines and aesthetic products to pharmacies and clinics across the UK
    Dudley, United KingdomBiotech & pharmaFounded 2011
  • Shafi Consultancy

    Clinical trial statistical programming and data services for pharmaceutical companies and contract research organizations
    Uxbridge, United KingdomBiotech & pharmaFounded 2001
    New on Evolc
  • Siinovia (UK)

    Develops and distributes niche generic and value-added medicines for healthcare markets and pharmaceutical partners
    Southall, United KingdomBiotech & pharmaFounded 2020
    New on Evolc
  • Simplex Molecular

    Molecular biology R&D, assay development and testing for research teams and businesses
    Manchester, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc
  • Sisaf

    RNA drug-delivery platform licensed to pharma partners, with a research reagent for labs planned
    Guildford, United KingdomBiotech & pharmaFounded 2006
  • Sitala Bio

    Develops medicines targeting harmful inflammation for patients with neurodegenerative and inflammatory diseases
    Cambridge, United KingdomBiotech & pharmaFounded 2021

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • HotjarMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Privacy & consent

  • CookieYesHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.